Empowering the Battle: Bioenhancers as Allies against Cancer Drug Resistance
CONCLUSION: Bioenhancers when combined with drugs can elicit pharmacological activity. They are generally combined with therapeutic agents at low doses, which increase the BA or therapeutic activity of active pharmaceutical ingredient (API). This review sheds light on the synthesis and classification of bio-enhancers. It also discusses different applications of bio-enhancers like piperine, ginger, quercetin, curcumin, etc. in the treatment of cancer. The review also presents some of the recent advancements in terms of nanocarriers for delivering API combined with bioenhancers.PMID:37957922 | DOI:10.2174/0113892010192038231107051715
Source: Current Pharmaceutical Biotechnology - Category: Biotechnology Authors: Pratiksha Vasant Jadhav Naga Jothi Prasath Saurabh Gajbhiye Utkarsha Rane Tejas Girish Agnihotri Shyam Sudhakar Gomte Aakanchha Jain Source Type: research
More News: Biotechnology | Cancer | Cancer & Oncology | Ginger | Nanotechnology | Physiology | Turmeric